Which medical device startups made the shortlist for the MedCity INVEST pitch competition?
Medical device companies presenting at INVEST this year span a wide range of segments from chronic wound treatment to dental care and women's health.
Medical device companies presenting at INVEST this year span a wide range of segments from chronic wound treatment to dental care and women's health.
Called Blueprint, the company will use the funding from Hyde Park Angels and Lightbank to expand its clinician outreach and grow its sales and engineering teams.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
AbbVie said Tuesday that the FDA had placed a partial clinical hold on all Venclexta studies in myeloma due to a higher rate of deaths in the Phase III BELLINI study.
MedCity INVEST is coming up next month. We've lined up a fantastic group of speakers for the two day conference in Chicago at the Ritz Carlton April 23-24 such as former Cleveland Clinic CEO Dr. Toby Cosgrove, Wellville Founder Esther Dyson, Bakul Patel of the FDA and more!
The deadline for applying for the MedCity INVEST Pitch Perfect competition April 23-24 in Chicago is now February 15. Applications from diagnostics and biopharma startups would be particularly welcomed.
The drugmaker said Monday that it had signed a deal with Teneobio to develop a BCMA-targeting bispecific antibody.
Visits to three health systems — Mercy Health in Grand Rapids, Michigan; Henry Ford Health System in Detroit; and OSF HealthCare in Peoria, Illinois — showcase how they're thinking creatively about simulation, startups, 3D printing and more.
The new center, which is expected to open in April, will be located in Elgin, Illinois, a northwest suburb of Chicago.
The First Stop Health funding round was led by Morningstar Chairman and Founder Joe Mansueto and Rich Gallun, the co-founder of employee benefits platform bswift.
Startups in the medical device, biopharma, diagnostics, and health IT sectors are invited to apply for the opportunity to pitch their businesses to a roomful of investors and healthcare stakeholders. The deadline for applications has been extended to February 8.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
As part of a new initiative called DNA10K, more than 10,000 NorthShore patients will gain access to Color's clinical-grade genetic testing and whole genome sequencing.
The company will use the $10 million from Blue Cross Blue Shield Venture Partners and Arboretum Ventures to add new team members who can help grow the business.
Through Epharmix, which offers condition-specific communication tools that allow care teams to remotely monitor patients, the health system can better connect with patients outside the hospital.
Mountain View, California-based Livongo Health, founded in 2014 by former Allscripts CEO Glen Tullman, has raised around $240 million in venture funding.
Following a successful pilot, the health system is using the Chicago startup's technology to offer a genetic risk assessment to patients.